GlobeNewswire
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
📈
AI Sentiment
Highly Positive
9/10
- Home
- MAIA
as of 12-29-2025 3:27pm EST
$1.43
$0.14
-8.92%
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 44.9M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.87 - $2.74 | Next Earning Date: | 11-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered MAIA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 71.33%
71.33%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of MAIA Biotechnology Inc. (MAIA)
Louie Ngar Yee
Buy
Director
MAIA Dec 22, 2025
Avg Cost/Share
$1.22
Shares
81,699
Total Value
$99,999.58
Owned After
1,248,888
SEC Form 4
CHAOUKI STEVEN M
Buy
Director
MAIA Dec 22, 2025
Avg Cost/Share
$1.22
Shares
40,849
Total Value
$49,999.18
Owned After
151,873
SEC Form 4
Smith Stan
Buy
Director
MAIA Dec 22, 2025
Avg Cost/Share
$1.22
Shares
57,189
Total Value
$69,999.34
Owned After
1,421,478
SEC Form 4
Smith Stan
Buy
Director
MAIA Dec 5, 2025
Avg Cost/Share
$1.20
Shares
13,740
Total Value
$16,440.83
Owned After
1,421,478
Luput Cristian
Buy
Director
MAIA Nov 28, 2025
Avg Cost/Share
$1.11
Shares
18,145
Total Value
$20,229.86
Owned After
437,628
SEC Form 4
Vitoc Vlad
Buy
Chief Executive Officer
MAIA Nov 28, 2025
Avg Cost/Share
$1.14
Shares
50,000
Total Value
$56,830.00
Owned After
881,421
SEC Form 4
Luput Cristian
Buy
Director
MAIA Nov 26, 2025
Avg Cost/Share
$1.08
Shares
20,000
Total Value
$21,616.00
Owned After
437,628
SEC Form 4
Smith Stan
Buy
Director
MAIA Nov 26, 2025
Avg Cost/Share
$1.04
Shares
15,000
Total Value
$15,582.00
Owned After
1,421,478
SEC Form 4
Vitoc Vlad
Buy
Chief Executive Officer
MAIA Nov 26, 2025
Avg Cost/Share
$1.05
Shares
22,000
Total Value
$23,018.60
Owned After
881,421
SEC Form 4
Luput Cristian
Buy
Director
MAIA Nov 25, 2025
Avg Cost/Share
$0.98
Shares
10,000
Total Value
$9,785.00
Owned After
437,628
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Louie Ngar Yee | MAIA | Director | Dec 22, 2025 | Buy | $1.22 | 81,699 | $99,999.58 | 1,248,888 | |
| CHAOUKI STEVEN M | MAIA | Director | Dec 22, 2025 | Buy | $1.22 | 40,849 | $49,999.18 | 151,873 | |
| Smith Stan | MAIA | Director | Dec 22, 2025 | Buy | $1.22 | 57,189 | $69,999.34 | 1,421,478 | |
| Smith Stan | MAIA | Director | Dec 5, 2025 | Buy | $1.20 | 13,740 | $16,440.83 | 1,421,478 | |
| Luput Cristian | MAIA | Director | Nov 28, 2025 | Buy | $1.11 | 18,145 | $20,229.86 | 437,628 | |
| Vitoc Vlad | MAIA | Chief Executive Officer | Nov 28, 2025 | Buy | $1.14 | 50,000 | $56,830.00 | 881,421 | |
| Luput Cristian | MAIA | Director | Nov 26, 2025 | Buy | $1.08 | 20,000 | $21,616.00 | 437,628 | |
| Smith Stan | MAIA | Director | Nov 26, 2025 | Buy | $1.04 | 15,000 | $15,582.00 | 1,421,478 | |
| Vitoc Vlad | MAIA | Chief Executive Officer | Nov 26, 2025 | Buy | $1.05 | 22,000 | $23,018.60 | 881,421 | |
| Luput Cristian | MAIA | Director | Nov 25, 2025 | Buy | $0.98 | 10,000 | $9,785.00 | 437,628 |
Latest MAIA Biotechnology Inc. News
MAIA Breaking Stock News: Dive into MAIA Ticker-Specific Updates for Smart Investing
Compare MAIA vs Leading Stocks
See how MAIA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MAIA MAIA Biotechnology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.